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Abstract 
The mu-opioid receptor (MOR) has been shown to mediate morphine induced 
analgesia, addiction, and tolerance. The expression of the major product of the MOR 
(MOR-1) gene has been found to be driven by two promoters, a distal promoter and 
a proximal promoter. The proximal promoter region has been shown in previous 
studies to be the major promoter for the regulation of MOR gene transcription in the 
adult mouse brain and embryonic development. Recent studies have shown that 
single-stranded DNA binding proteins (such as Poly C Binding Protein) are involved in 
transcriptional regulation of mouse MOR gene. Poly C binding protein (PCBPs) is 
categorized in the family of hnRNP's, containing multiple K-Homology (KH) domains, 
which is involved in RNA stabilization, translational activation, and gene silencing. In 
this study, we attempted to determine the trans-activation domains of PCBP and 
examine the regulatory effects of each trans-activation domain of PCBP in MOR 
transcription. Mouse neuronal cells (N2A) were transiently transfected with various 
truncation constructs of PCBP to determine which domains were important in trans­ 
activation. Our preliminary data suggests that at least two KH domains were 
required for PCBP to display its trans-activation activity. 
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Introduction 
Opioids have a spectrum of pharmacological and physiological effects that 
include sedation, euphoria, respiratory depression, and analgesia (Rossi et. al, 
1994), along with tolerance and dependence upon chronic administration (Law et al, 
1999). Three different opioid receptor types have been identified that can interact 
with opioids, which include the mu (µ), kappa (K), and delta (5) opioid receptors. 
These receptors belong to the seven transmembrane domain receptor superfamily 
coupled to guanme nucleotide regulatory proteins (G-proteins), also called the GPCR 
(G-protein coupled receptor) superfamily (Kieffer et al, 1995). Each opioid receptor 
mediates its effects by first activating heterotrimeric G-proteins that couple to 
intracellular effector enzymes and channels (Brillet et al, 2003). Opioid receptors 
undergo receptor phosphorylation, desensitization, internalization, and recycling 
upon agonist activation. Of the three opioid receptors, the mu opioid receptor (MOR) 
is mainly distributed in the central nervous system and in large part involved in 
morphine induced analgesia, addiction, tolerance and dependence (Keiffer et at, 
1996). 
The MOR gene shows approximately 50-70% homology to the genes encoding 
for the 5 - ( D O R - 1 ) ,  K-(KOR-1) and orphan (ORL!) receptors (Koch et al, 1998). The 
MOR gene is over 200 kb in size and several different splice variants have been 
identified, such as differing only in the presence or absence of a set of amino acids at 
the intracellular carboxyl terminus. The splice variants exhibit differences in their 
rate of onset and recovery from agonist-induced internalization, but their 
pharmacology does not appear to differ in ligand binding assays (Pan et al, 2002). 
Two MOR splice variants, MOR-lA and MOR-1B, were identified shortly after cloning 
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of the MOR-1 gene (Bare et al., 1994, Zimprich et al., 1995). MOR-1A was identified 
first rn the human cell line and a similar murme variant has been isolated. MOR-18, 
encoded by exons 1, 2, 3, and 4 in the munne variant was first isolated from the rat 
and differs from MOR-1A in that it contains an alternatively spliced exon 5 instead of 
the original exon 4. Of the various splice variants, the MOR-1 gene is the most 
prominent form and is encoded by four exons, exons 1, 2, 3 and 4 (Min et al, 1994). 
The MOR-1 is a seven transmembrane protein that spans over 356 amino acids in 
size with its N-terminus (amino) facing the extracellular space and the C-terminus 
(carboxy) facing the intracellular space. 
Previous studies have shown that the mouse MOR contains three different 
promoters, a distal and proximal promoter, located approximately within 1 Kb 
upstream of the translation start site (Ko et al, 1997) and a third promoter located 
approximately 10 KB upstream of the translation start site (Pan et al, 2002). Both 
the distal and proximal promoters lack a consensus TATA box sequence, a promoter 
sequence involved in gene regulation in eukaryotes (Ko et al, 1997). The distal 
promoter is located 794 bp upstream of the translation start site and initiates 
transcription from a single transcription initiation site (Liang et al, 1995). The 
proximal promoter initiates MOR transcription from four transcription mitiatron sites 
that are located in a region spanning from 291 to 268 bp upstream of the translation 
start site (Min et al, 1994). The third promoter has been shown to regulate the 
expression of MOR variants containing exon 11. This promoter contarns a TATA box 
and is flanked by positive and negative regulatory elements (Pan et al, 2002). It has 
been shown using quantitative reverse transcriptase-PCR with mRNA from the adult 
mouse brain that the proximal promoter is approximately twenty-fold more active 
than the distal promoter (Ko et al, 1997). 
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Data from transfectlon analysis indicated that the proximal promoter directs 
neuronal subtype expression (Ko et al, 1997). Furthermore, it was shown that the 
MOR transcription is mainly initiated by the proximal promoter in the mouse adult 
brain and these results suggest that it is the major functional promoter (Ko et al, 
1997). 
It has been shown that several DNA binding proteins bind and regulate MOR 
gene expression. Sp factors (double stranded DNA binding protein) and mPy (mar 
polypyrimidine binding protein - an unidentified protein) have been shown to be 
critical in regulating transcription of MOR. In addition to double stranded DNA 
binding proteins, single·stranded DNA binding proteins may also be involved in the 
transcriptional regulation of the MOR gene (Ko et al. 2000). 
A single-stranded DNA binding protein, named poly C binding protein (PCBP), 
was recently identified from a mouse brain library using the yeast one hybrid 
screening system (Ko and Loh, manuscript submitted). It has been shown that 
PCBP can trans-activate the MOR-gene by interacting with the proximal promoter of 
the MOR gene. The PCBP protein is categorized under the K·Homology (KH) domain 
superfamily of nucleic-acid binding proteins, one of which is a well-characterized 
protein known as heterogeneous nuclear ribonucleoprotein K (hnRNP K Homology). 
The KH domain has been shown to be an RNA-binding motif (Adinolfi et al, 1999). 
hnRNP K is an evolutionarlly conserved factor that is found in the nucleus, cytoplasm 
and mitochondria. hnRNP's have been shown to be involved in chromatin remodeling 
(Denisenko and Bomsztyk, 2002), transcription (Michelotti et al, 1996; Du et al, 
1998), pre mRNA splicing (Expert-Bezancon et al, 2002), mRNA export (Michael et 
al, 1997), and translation (Ostareck et al, 1997) along with attenuating steroid 
hormone receptor gene trans-activation {Chen et al, 2003). Many of these reactions 
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have been shown to be regulated by K protein phosphorylation that is either induced 
by changes in the extracellular environment or by activity of specific ligands 
(Ostrowski et al, 2003). 
Poly(C)�binding proteins {PCBP) are approximately 37-39 kDa in size and 
belong to the KH domain superfamlly. PCBPs can be divided into two groups, hnRNP 
K/J and alphaCPs {l-4). These proteins are involved in RNA stabilization (Weiss and 
Uebhaber, 1994,1995; Hotcik & Uebhaber 1997), translational activation (Blyn et al, 
1997; Gamarnik and Andino 1997), and translational silencing (Ostareck et al, 
1997; Collier et al., 1998). hnRNPs are a family of over 20 proteins that contribute 
to a complex around nascent pre-mRNA and are thus able to modulate RNA 
processing. (Chen et al, 2003). 
The presence of three KH domains In PCBP leads one to question which 
domain or combination of domains Is essential for its optimal trans-activation of the 
MOR gene. In this study, we examine which domains of PCBP are important tor its 
trans-activation activity on the mouse MOR proximal promoter. 
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Methods and Materials 
Plasmid construction and 1solat1on - 
The mammalian expression vector, pcDNA3 (Invitrogen, Carlsbad, CA), was used to 
construct the PCBP expression plasmids. The full length of a PCBP cDNA fragment 
was Inserted into the multiple cloning site of the vector, which resulted in the 
pcDNA3-PCBP plasmid. For construction of t:iVR deletion construct, the pcDNA3- 
PCBP plasmid was digested with Kpnl and Bgl II restriction enzymes (150 minutes at 
37°C) and purified by agarose gel electrophoresis. Concurrently, another pcONA3· 
PCBP fragment digestion with Nsil and Xhol restriction enzymes (150 minutes at 
37°C). The digested fragments were then purified by agarose gel electrophoresis 
and the fragments were isolated and purified via Gene Clean kit (Bio 101, Carlsbad, 
CA) and then relegated and then inserted into the pcDNA3 vector. KH23 was 
generated by utllizing .ti.VR and subjecting It to EcoRV and Xhol restriction enzyme 
digestion and purification for relegation into the pcDNA3 vector. For construction of 
other constructs (KHl, KH2, KH3, VR, KH23VR), PCR amplification {described later) 
was performed to prepare the desired insert fragment that was then inserted into the 
multiple cloning sites of the pcDNA-3 plasmid vector (Figure lb). Constructs from 
PCR amphfication were digested for 150 minutes at 37°C with Kpnl and Xhol 
restriction enzymes and subjected to gel electrophoresis and visualized by 
Alphalmager (Alpha Innotech, San Leandro, CA) for confirmation. 
E. CQ!i Transformation - 
Plasmid ONA was added to 100 µL of E. coli competent cells and incubated on ice for 
30 minutes. The cells were then heat shocked for 1 minute in a 42 °C water bath 
1 1  
and then chilled for 2 minutes on ice. 250 µL of Luria Broth media was added to the 
cells and incubated for 60 minutes at 37 °C and then plated on Luria Broth agar 
plates with lOµg/µL ampicillin for positive selection. The plates were incubated 
overnight at 37 °C. 
large Scale Plasmid Preparation - 
One milliliter (ml) of transformed cultured E. coli was added to 250 ml Luria Broth 
media with ampicillin and grown overnight at 37 °C. The large scale culture (250 
ml) was then transferred to large centrifuge bottles and centrifuged at 6000 rpm for 
15 minutes at 4 °C (RCSC). The plasmid DNA was extracted utilizing QIAGEN 
(Valencia, CA) Plasmid Maxi Kit where the £. coli pellet was resuspended in 10 ml of 
Pl (SOmM glucose, lOmM EDTA (pH 8) 25mM Tris HCI (pH 8) with RNase A) buffer. 
The cells were then lysed by additmn of 10 ml of P2 (0.2M NaOH with 1 % SDS). 
Ten ml P3 (5 M potassium acetate, glacial acetic acid) buffer was added to neutralize 
the reaction and the 30 ml mixture was then centrifuged at 16,000 rpm at 4 °C for 
35 minutes. The plasmid was then purified through a column and then washed twice 
with QC (100% Ethanol) wash buffer. The DNA was then eluted using 15 ml of QF 
Elution buffer and 11 ml of chilled isopropanol was then added. The mixture was 
centrifuged at 9000 rpm at 4 °C for 35 minutes. The pellet was then washed with 3 
ml of 70% ethanol and then centrifuged on a tabletop centrifuge. The resulting DNA 
pellet was resuspended m 300 µl of TE solution. 
Cell culture- 
Neuronal mouse cells (N2A) (American Type Culture Collection, Manassas, VA) were 
grown in Dulbecco's Modified Eagle Medium (DMEM) with 10% heat inactivated fetal 
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calf serum (FCS) in an atmosphere of 10% C0
2 
at 37 °C and 90% air. Cell 
monolayers were grown in T-75 cm2 flasks (Fisher Scientific, Tustin, CA) and 
passaged when the monolayers reached 70% confluence by visual examination. 
Cells were passaged by washing with 10 ml of DMEM serum free medium, incubating 
with 7.0 ml of 0.1% trypsin/EDTA in phosphate buffered saline (PBS) and 
resuspended after centrifugation in 10 ml of DMEM with 10% FCS. An aliquot of 
resuspended cells were transferred to a new T- 75 cm2 flask (Fisher Scientific, Tustin, 
CA) containing 25 ml DMEM with 10% FCS and incubated at 37 °C in an atmosphere 
of 10% C02 and 90% air. 
Transient Transfection- 
Cells were transfected following the manufacturer's protocol using a Superfect 
lipofection method (Qiagen, Valencia, CA). Neuronal mouse celfs (N2A) were 
incubated overnight in 6-well plates at a concentration of O. 7x106 cells per well prior 
to the beqmmnq of the experiment. Cells were transfected with equimolar amount of 
each test plasmid {0.1 µg, 0.5 µg, 1.0 µg). The amount of DNA used was within the 
linear range of the relationship between luciferase activity and the amount of DNA 
transfected. Cells were washed twenty-four hours after transfection and 4 ml DMEM 
with 10% FCS was added to each well. Forty-eight hours after transfection, cells 
grown to confluence were washed twice with Phosphate buffered saline (PBS) and 
lysed with Reporter Lysis Buffer (Promega, Madison, WI). The resulting lysate was 
subjected centrifuged at 12000 rpm and the supernatant was separated from the cell 
debris and used for activity assay. To control for differences in transfection 
effioency from dish to dish, one fifth molar ratio of pCHllO (internal control) 
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containing the j3-galactosidase gene driven by the SV40 promoter was included in 
each transfection and used for normalization. 
Luciferase and B-qalactosidase assays- 
Ten microliters of cell lysates were mixed with 100 µL of Juciferin, and the light 
emission from the reaction was measured and recorded in relative light units (RLUs) 
by a Lumat LB 9507 machine (Berthold Technologies, Drescher, PA). For 13- 
galactosidase activity assay, 7 µL of substrate and light emission accelerator mixture 
in a 1:  100 dilution were added to 70 µL of cell lysate and incubated for 45 minutes at 
room temperature. The mixture was then mixed with 100 µL of substrate and the 
emitted light was measured and recorded by Lu mat LB 9507 (Berthold Technologies, 
Drescher, PA). 
In vitro coupled transcription and translation - 
In vitro transcription and translation was carried out with a final reaction mixture of 
20 µL using Promega TNT Coupled Transcription/Translation Systems Kit {Promega, 
Madison, WI). The mixture was comprised of 12.5 µL Rabbit Rettculocvte Lysate, 0.5 
µg DNA, 25 units T? RNA polymerase,10 µC1 355-methionine, 0.5 µL 1 mM NTPs, 1.5 
mM MgCl2, and 0.4 µL 1 mM amino acid mix. The reaction mixture was incubated at 
30 °C for 90 minutes and 1 µg of RNAse-A was added to stop reaction and destroy 
peptidyl-tRNA. The reaction was further incubated for 10 minutes at 30 °C. The 
resulting transcription and translated protein products were analyzed using SDS­ 
PAGE. 
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Sodium Dodecyl Sutfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)- 
A 20% polyacrylamide gel was prepared. The samples were etectrophoresed and the 
resulting gel was then dried using a BioRad 583 Gel Dryer (Bio-RAd, Hercules, CA). 
The gel was then exposed in a phosphoimager cassette overnight at room 
temperature. The signals on the cassette were then detected the following day using 
a Storm 840 Phosphorimager system (Molecular Dynamic Inc., Piscatway, NJ) 
DNA Sequencing - 
DNA plasmids were amplified using PCR with addition of 3' and S' primers (M13 Rev - 
GGAAACAGCTATGACCATG, Sp6 - AGCTATTTAGGTGACACTATAG, T7 - 
TAATACGACTCACTATAGGG), along with Taq DNA polymerase. The samples were 
then subjected to electrophoresis utilizing a DNA sequencing gel (National 
Diagnostics, Atlanta, GA) and the resulting gel was dried using a BioRad 583 Gel 
Dryer (Bio-RAd, Hercules, CA). The gel was then exposed in a phosphoimager 
cassette overnight at room temperature. The signals were then detected the 
following day using a Storm 840 Phosphorimager system (Molecular Dynamic Inc., 
Piscatway, NJ) 
Polymerase Chain Reaction (PCR) � 
Polymerase Chain Reaction (PCR) amplification was performed uttlizmq lx PCR buffer 
in reaction mix buffer containing 1 µL Taq DNA polymerase {Promega, Madrson, WI), 
0.5 µg PCBP cDNA template, 10 nM sense primer for KSP (5'-GGTACCATGGACGC­ 
CGGTGTGACTG-3'), 10 nM antisense primer for KSP (5'-CTCGAGTTATCTAATGGGT­ 
GGTTTGAGTAGATGC-3') in a final volume of 10 µL. PCR was carried out by 35 
cycles with each round consisting of 1 minute at 93 °C, 30 seconds at 68 °C and 30 
15 
seconds at 72 °C. The resulting PCR product was resolved on 2% agarose gel and 
subjected to ethydium bromide staining and visualized by Alphalmager (Alpha 
Innotech, San Leandro, CA). 
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Results 
Construction of Plasmids 
We utilized a mammalian expression system to achieve our goal of 
determining which domains of PCBP were necessary for trans-activation. The 
mammalian expression vector, pcDNA3, was utilized and the full length cDNA 
fragment of PCBP (Figure lA) was inserted into multiple cloning sites on the vector 
(Figure 18). With the pcDNA3-PCBP plasmid constructed, we then created 3' and 5' 
deletion constructs. These deletion constructs were created either as single domain 
deletions, double domain deletions, or triple domain deletions (Figure lA}. For the 
generation of some constructs, PCR inserts were created and the insert size was 
confirmed using agarose gel electrophoresis (Figure 18) before being isolated, 
purified, and subcloned into the multiple cloning site of the vector. 
A 
VR KHIII • full Length PCBP 
I KHI I KHU I KHIII • Single Domain Deletion 
KHU I KHIII • Double Domain Deletion 
I KHI I Triple Domain Deletion 
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B 
Ampicillin pcDNA3 5.4kb 
Neomycin 
SV40 pA. 
�� pUco,i / ( 
Figure 1. A. Schematic depiction of the full length PCBP fragment and its truncated 
constructs. B. The mammalian expression pcDNA3 vector (Irwttroqen, Carlsbad, 
California) ts driven by a CMV promoter. The full length of PCBP and truncated PCBP 
DNA fragments were inserted into the cloning site of this vector. 
Confirmation of Identity of Constructs 
The identity of these deletion constructs were confirmed using restriction 
enzyme digestion (Asp718 and Xhol). The samples were then subjected to gel 
electrophoresis and analyzed to look for the insert band size located approximately 
100 bp in size for triple domain deletions (Figure 2A). The identity of these 
constructs was further confirmed using DNA sequencing (Figure 2B). 
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A 
lKB VR KH3 KHl KH2 
B 
Vector 
Insert 
Figure 2. A. Electrophoretic analysis of a deletional constructs plasmids, The 
identity of deletion constructs was verified by confirming insert band size by 
restriction enzyme digestion. 8, DNA sequencing analysis of various constructs was 
performed to verify the identity of the correct construct. 
Molecular Weight Examination of in vitro Expressed PCBP 
The molecular weight of the proteins generated by m vitro transcription and 
translation method was then examined using SDS-PAGE. The result of SDS-PAGE 
analysis is shown in Figure 3. As shown, the single domain proteins were expressed 
at approximately 10 kDa with the full length PCBP shown at approximately 38 kDa. 
The construct missing one domain, the VR domain in this case, was shown to be 
about 27 kDa in size. 
19 
46kDa 
30kDa 
20kDa 
14.3kDa 
- 
-- 
38kDa 
.,,,,... .._ 27kDa 
Lane 1 2 3 4 5 6 
Figure 3. The full length (lane 5) or truncated forms of PCBP (lane 3-4 and 6) were 
translated using pcDNAJ-PCBP or pcDNA3-PCBP deletion plasmids via in vitro 
transcription/translation method, individually. These translated proteins were then 
subjected to a 20% polyacry/amide gel electrophoresis and analyzed. Lane 1, 
pcDNA3 vector alone as a negative control. No translated protein was visualized; 
lane2, protein markers; lane 3, KHl; lane 4, KH3, lane 5, full length of PCBP and 
lane 6 LI VR proteins. The gel was then dried and subjected to the autoradiography 
using a Molecular Dynamic Storm 840 Phosphorimager system. 
Transfection Analysis 
We next setup the transfection system for determining the trans-activation 
activity of PCBP on the mouse MOR gene. Figure 4 shows the cc-transfectton 
analysis with various amounts of DNA. Here we show that with increasing amounts 
of DNA (0.1 µg, 0.5 µg, 1.0 µg), PCBP was able to trans-activate the reporter gene 
driven by the MOR promoter in a dose-dependent manner. 
20 
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400 
350 
300 
" ·; 
'fl 250 
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1 200 
• 
i 150 - 
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50 - 
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0.1 0.5 
Amount of DNA(ug) 
uPCBP 
oDNAJ 
Figure 4. Mouse neuronal (N2A) were co-transfected with luciferase reporter 
plasmids driven by MOR promoter and the PCBP (pcDNA3-PBCP) construct. The 
trans-activation activity was presented as relative luciferase ectsvsties (RLU), with the 
act1v1ty of pcDNA3 (vector) arbitrarily defined as 100%, 
Transfection Analysis of Single Domain Deletions 
With the transfection system setup, we analyzed the trans-activation ability of 
various deletion constructs of PCBP in mouse neuronal cells (N2A) and examine their 
expression activities. Figure 5 shows the result of this transfection assay where 
pcDNA3 was used as a negative control and full length PCBP was used as the positive 
control. The preliminary data of transfection analysis shows that the deletion of one 
domain lead to a decrease in activity but did not result in a total loss of trans- 
activation activity. 
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Figure S. Mouse neuronal (N2A) cells were co-transfected with luciferase reporter 
plasmids ddven by MOR promoter and the PCBP (pcDNA3-PCBP) or PCBP deletion 
expression constructs, as indicated on the left of the figure. The trans-activation 
activity of the full length or deletional PCBP on the mouse MOR promoter was 
presented as relative luciferase activities (RLU), with the activity of pcDNA3 
arbitrarily defined as 100%. Each increasing bar represents a dose response from 
0.1 µg (gray), 0.5 µg (black), and 1.0 µg (white) of the PCBP or respective PCBP 
deletional plasmid. 
Transfection Analysis of Double Domain Deletion Mutants 
Furthermore, we sought to examine the trans-activation activity utllizing 
double domain deletion mutants. Figure 6 shows the transtecnon analysis with two 
domains of the PCBP deleted. Our preliminary data shows that double domain 
deletion resulted in a sharp decrease in the trans-activation activity that was lower 
than In single domain deletions (Figure 4 ). 
22 
" 
Ktlli ·1 
" 
.... IQ�., 
(I,',, 
[ f!"I! 
"" "' "'" "" 
' 
., 
'" '" "' 
C!i' ye "i s.e 
l<tl.itrvt AJ;Uvi� 
Figure 6. Mouse N2A cells were co-transfected with tuaterese reporter plasmids 
driven by MOR promoter and the PCBP (pc0NA3-PCBP) or PCBP deletion expression 
constructs, as indicated on the left of the figure. The trans-activation activity of the 
full length or deletional PCBP on the mouse MOR promoter was presented as RLU, 
with the activity of pcDNA3 arbitrarily defined as 100%. Each bar represents a dose 
response from 0.1 µg (gray), 0.5 µg (black), and 1.0 µg (white) of the PCBP or 
truncated CPBP plasmid. 
Transfection Analysis of Triple Domain Deletion Mutants 
Finally, the trans-activation activity of triple domain deletion constructs were 
examined. Figure 7 shows each of the single domain constructs missing three of 
other domains. Compared with the negative control, pcDNA3, it was shown that no 
construct containing a single domain had the abrlity to trans-activate the reporter 
gene compared to the construct with the full length PCBP. 
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Figure 7. Mouse N2A cells were co-transfected with Juciferase reporter plasmids 
driven by MOR promoter and the PCBP (pcDNA3-PCBP) or PCBP deletion expression 
constructs, as indicated on the left of the figure. The trans-activation activity of the 
full length or deletional PCBP on the mouse MOR promoter was presented as RLU, 
with the activity of pcDNA3 arbitrarily defined as 100%. Each bar represents a dose 
response from 0.1 µg (gray), 0.5 µg {black), and 1. 0 µg {white) of the PCBP or 
truncated CPBP plasmid. 
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Discussion 
Previous studies from our laboratory have shown that Poly(C)-Binding Protein 
(PCBP) can trans-activate the proximal promoter of the mouse mu-opioid receptor 
(MOR) gene (Ko and Loh, manuscript submitted). PCBP is a well-known RNA 
binding protein; however, rt has never been documented as a regulatory factor which 
is able to regulate a gene expression at the DNA level, nor has the molecular basis of 
how PCBP can act as a transcriptional regulator and regulate the MOR gene 
expression been investigated. In this report, we therefore investigated the molecular 
basis of how PCBP can regulate the MOR promoter activity by determining which 
domains of PCBP are necessary for the optimal trans-activation on the MOR gene at 
the DNA level. 
The following is a diagram of the structure of PCBP where PCBP contains three 
copies of a KH motif (RNA-binding K homologous motif), which has been rdentrfled in 
a wide spectrum of RNA-binding proteins (Stom! et al, 1993). This motif was first 
described for hnRNP K, a member of the hnRNP family (Adinolfi et al, 1999). 
N-Terminus 
I KHI I KHII VR 
C·Terminus 
KHIII • 
PCBP is a member of hnRNP family or a KH domain family. The KH domain is 
identified as a RNA binding domain. The arrangement of each of the KH motifs 
within all members of the hnRNP family is similar where two KH domains are located 
at the N-terminus in a consecutive sequence with a third KH domarn located at the 
C-terminus that is separated by a varying sequence (VR). Within PCBP, no other 
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RNA-binding motif has been found. The presence of three KH domains tends to the 
question of which domain(s) is(are) necessary for its regulatory role at the DNA 
level. 
With the transfection system successfully established in a neuroblastoma cell 
model system (N2A), functional analysis study further confirmed that PCBP is in fact 
able to trans-activate the mouse MOR promoter with increasing amounts of the 
plasmid DNA of PCBP (Figure 4). Therefore, in order to determine which domains of 
PCBP were necessary for the optimal trans-activation, multiple deletion constructs, 
containing the KH domains in varying combinations, were generated and tested. 
Functional analysis using triple domain deletion mutants demonstrated the 
abolishment of all trans-activation activity of PCBP (Figure 7). This data suggests 
that one domain alone does not have the ability to induce trans-activation by PCBP 
itself. However, double domain deletion mutants displayed an increase in the 
promoter activity compared to triple domain deletions (Figure 6). An implication 
here could be that one domain may contain the binding domain, while the other 
contains the trans-activation domain. Furthermore, trans-activation activities of 
double domain deletion mutants are not as great as those usmg single domam 
deletion constructs (Figure 5), suggesting that multiple domains could be necessary 
for optimal activity. Collectively, these data demonstrated that the overall trans­ 
activation is not dependent on just one domain but rather a combination of domains. 
There are several possibilities of why multiple domains are needed. First, the 
trans-activation domain and DNA binding domain may be located at different regions 
of PCBP, therefore at least two domains are required. Second, the presence of 
multiple domains may result in increasing its binding affinity and/or protein stability, 
because each KH domain may be composed of a conserved yet different and 
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independent DNA binding unit. This notion may be further supported by the 
complexity of the RNA binding properties of KH domain family proteins. A previous 
study showed that KH domains of hnRNP Kand PCBP can bind the poly r(C) RNA 
sequence, however, each KH domain differentially binds to RNA sequences (Dejgaard 
and Leffers, 1996). In addition, it has been shown that only the first KH domain of 
hnRNP K was able to function as an independent RNA binding unit (Silvera et al., 
1999), whereas modification or deletions of each of the three KH domains in hnRNP 
K protein have been shown to diminish or decrease its RNA binding capability (Siami 
et al, 1994), indicating the necessity for the presence of multiple KH domains. Third, 
the presence of multiple domains of PCBP may simply retain correct conformation for 
its interaction or increase the frequency of interaction with other factors. Our 
present study indicated that the structure of PCBP can be fine tuned by combrnation 
of different domains with sequence variations, which then results in its trans­ 
activation activity and sequence-specific DNA binding profile. 
It also can be noted that the presence of the VR region with the KH2 
construct (Figure 6 and 7) resulted in an increase in trans-activation activity, which 
is further established with the increase in activity seen with the addition of VR region 
to the KH23 construct (Figure 5 and 6). These observations imply that the VR 
region, though not established as an RNA-binding motif, may contain some 
properties that allow it to take part in trans-activation. To further understand the 
molecular basis of PCBP as a transcription regulator on the MOR gene expression, 
future studies will focus on not only the construction of more deletion constructs to 
confrrm which domains are crucial for trans-activation, but the identification of DNA 
binding domains of PCBP on the proximal promoter of the MOR gene will also be 
investigated. 
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Conclusion 
In summary, we have explored the necessary domains of PCBP that are 
required for optimal trans-activation of the proximal promoter on the mouse MOR 
gene. We have successfully constructed several deletion plasmids that were 
confirmed using gel electrophoresis, SDS-PAGE, and gene sequencing. Next, we 
were able to show that PCBP can trans-activate the MOR gene in a dose dependent 
manner in mouse neuronal (N2A) cells. 
In this study, we were able to show that triple domain deletion constructs 
of PCBP had lost ability to trans-activate the MOR gene (Figure 7). The trans­ 
activation activity was enhanced upon presence of another domain as shown by 
double domain deletion constructs (Figure 6). Our results also show that deletion of 
one domain lead to slight decrease in trans-activation activity of PCBP on the MOR 
promoter (Figure 5). Collectively, this data suggests that no single domain of PCBP 
has critical control over trans-activation. We hypothesize that multiple domains are 
necessary for optimal trans-activation. Also, it is possible that certain domains may 
contain the binding domains while others contain the trans-activation domain and 
deletion of either resulted in decrease of trans-activation activity. 
Our preliminary data suggest that it is necessary for completion of more 
domain deletion constructs to further examine their effects on trans-activation. Also, 
the results seen in this study ought to be further confirmed using other trans­ 
actrvation methods, such as yeast one hybrid systems. Lastly, rdentiflcatron of the 
DNA binding domains of PCBP will be helpful m characterizing the mechanism of 
action of the PCBP protein. 
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